OlMesartan Lactone IMpurity

OlMesartan Lactone IMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White Solid

Verwenden

Olmesartan Lactone Impurity (Olmesartan EP Impurity B) is a cyclic ester impurity of Olmesartan (O550000).

OlMesartan Lactone IMpurity Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

OlMesartan Lactone IMpurity Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	32480	60
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28180	58
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14336	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
Career Henan Chemica Co	+86-0371-86658258 15093356674;	laboratory@coreychem.com	China	30255	58
ANHUI WITOP BIOTECH CO., LTD	+8615255079626	eric@witopchemical.com	China	23556	58
Finetech Industry Limited	+86-27-87465837 +8618971612321	info@finetechnology-ind.com	China	9702	58
CR Corporation Lomited		fred.wen@crcorporation.cn	CHINA	12069	58
Hangzhou Huarong Pharm Co., Ltd.	571-86758373 +8613588754946	sales@huarongpharm.com	CHINA	3149	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12382	58

849206-43-5()Verwandte Suche:

---

• 3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-furo[3,4-d]imidazol-4-one
• Olmesartan Lactone Impurity A
• Olmesartan impuirty B
• Olmesartan MedoxomiI Impurity B
• Olmesartan Related Compound A
• Olmesartan Medoxomil EP Impurity B, RNH-6352
• 3-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6,6-dimethyl-2-propyl-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one
• Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one)
• 3,6-Dihydro-6,6-diMethyl-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-4H-Furo[3,4-d]iMidazol-4-one
• OlMesartan EP IMpurity B (OlMesartanLactone)
• OlMesartan EP IMpurity B
• 4H-Furo[3,4-d]iMidazol-4-one, 3,6-dihydro-6,6-diMethyl-2-propyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]- 4-yl]Methyl]-
• Olmesartan Medoxomil impurity 11/Olmesartan Medoxomil EP Impurity B/Olmesartan Lactone Impurity/3-((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-6,6-dimethyl-2-propyl-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one
• Olmesartan Medoxomil-2
• 3-((2'-(4H-1,2,3-triazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6,6-dimethyl-2-propyl-3,6-dihydro-4H-furo[3,4-d]imidazol-4-one
• Olmesartan Impurity B
• Olmesartan Medoxomil EP Impurity B
• 6,6-dimethyl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]furo[3,4-d]imidazol-4-one
• 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one
• Olmesartan Medoxomil Impurity C(Olmesartan Medoxomil EP Impurity B)
• Olmesartan Impurity 2(Olmesartan Medoxomil EP Impurity B)
• Olmesartan medoxomil B
• 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
• 4,4-Dimethyl-2-propyl-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]furo[4,3-d]imidazol-6-one
• Olmesartan Impurity B (Lactone Impurity)
• Olmesartan EP Impurity B/ Olmesartan Related Compound A (Olmesartan Lactone)
• Olmesartan EP Impurity B Olmesartan Medoximil USP Related Compound A
• 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-pro...
• Azilsartan medoxomil impurity240
• Olmesartan Medoxomil Related Compound A (1-{[2''-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethy (1478378)
• Olmesartan Lactone
• Olmesartan Medoxomil Impurity B(EP)
• Olmesartan Medoxomil USP Related Compound A
• Olmesartan ester impurity B
• Olmesartan EP imp B
• OlMesartan Lactone IMpurity C
• Olmesartan EP Impurity B Olmesartan USP RC A
• Olmesartan gama-Lactone
• Olmesartan Lactone Impurity
• 849206-43-5
• Aromatics
• Heterocycles
• Intermediates & Fine Chemicals
• Metabolites & Impurities
• Pharmaceuticals